The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)
1 other identifier
observational
106
1 country
1
Brief Summary
The study is to show the prognostic factor of HRV parameter and cardiac fibrosis markers in critical illness patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 29, 2013
CompletedFirst Posted
Study publicly available on registry
November 25, 2013
CompletedNovember 25, 2013
November 1, 2013
1 year
October 29, 2013
November 20, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Heart Rate Variability and serum cardiac fibrosis markers in critical illness patients
1. Outcome measurement: The measure is a composite outcome measure consisting of multiple measures (results to be reported as a single value for each Arm/Group), no changes are required 2. List the primary condition or disease being studied Shock needing ECMO support
2-4weeks
Study Arms (2)
Study group
ECMO Patients survived
Control
ECMO Patient died
Eligibility Criteria
adult age\>18 years old
You may qualify if:
- critical illness patients who are with cardiogenic shock, with ECMO or IABP support, or with APACH II score \>25)
You may not qualify if:
- pacemaker rhythm, not sign the permit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 29, 2013
First Posted
November 25, 2013
Study Start
May 1, 2008
Primary Completion
May 1, 2009
Study Completion
December 1, 2009
Last Updated
November 25, 2013
Record last verified: 2013-11